Published in Curr Hypertens Rep on April 01, 2008
Rapid depot-specific activation of adipocyte precursor cells at the onset of obesity. Nat Cell Biol (2015) 2.09
Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol (2012) 1.99
Adiponectin, a key adipokine in obesity related liver diseases. World J Gastroenterol (2011) 1.41
Ancestral dichlorodiphenyltrichloroethane (DDT) exposure promotes epigenetic transgenerational inheritance of obesity. BMC Med (2013) 1.37
Body mass index, waist circumference, and the risk of type 2 diabetes mellitus: implications for routine clinical practice. Dtsch Arztebl Int (2010) 1.33
Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females. Endocrinology (2009) 1.32
Vascular disease and dementias: paradigm shifts to drive research in new directions. Alzheimers Dement (2012) 1.21
Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity. Int J Endocrinol (2013) 1.16
Perspective: Does brown fat protect against diseases of aging? Ageing Res Rev (2009) 1.07
Naringin improves diet-induced cardiovascular dysfunction and obesity in high carbohydrate, high fat diet-fed rats. Nutrients (2013) 1.01
Role of educational level in the relationship between Body Mass Index (BMI) and health-related quality of life (HRQL) among rural Spanish women. BMC Public Health (2009) 0.96
High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity. J Clin Endocrinol Metab (2009) 0.95
Lipotoxicity and cardiac dysfunction in mammals and Drosophila. Crit Rev Biochem Mol Biol (2011) 0.90
Obesity and Staphylococcus aureus nasal colonization among women and men in a general population. PLoS One (2013) 0.89
The Adipose Tissue Microenvironment Regulates Depot-Specific Adipogenesis in Obesity. Cell Metab (2016) 0.86
Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls. BMC Cancer (2012) 0.83
Abdominal adiposity distribution in diabetic/prediabetic and nondiabetic populations: a meta-analysis. J Obes (2014) 0.81
A green algae mixture of Scenedesmus and Schroederiella attenuates obesity-linked metabolic syndrome in rats. Nutrients (2015) 0.80
Adiponectin gene therapy ameliorates high-fat, high-sucrose diet-induced metabolic perturbations in mice. Nutr Diabetes (2012) 0.80
Evaluation of serum lipid profile, body mass index, and waistline in Chinese patients with type 2 diabetes mellitus. Clin Interv Aging (2016) 0.79
Grape seed proanthocyanidins and metformin act by different mechanisms to promote insulin signaling in rats fed high calorie diet. J Cell Commun Signal (2013) 0.78
AMPK activation--protean potential for boosting healthspan. Age (Dordr) (2013) 0.78
Proportion of gestational diabetes mellitus attributable to overweight and obesity among non-Hispanic black, non-Hispanic white, and Hispanic women in South Carolina. Matern Child Health J (2014) 0.77
An approach to the etiology of metabolic syndrome. Colomb Med (Cali) (2013) 0.77
Alamandine reduces leptin expression through the c-Src/p38 MAP kinase pathway in adipose tissue. PLoS One (2017) 0.75
Enzymatic intracrine regulation of white adipose tissue. Horm Mol Biol Clin Investig (2014) 0.75
Cucurbitacin E reduces obesity and related metabolic dysfunction in mice by targeting JAK-STAT5 signaling pathway. PLoS One (2017) 0.75
Resistin - the link between adipose tissue dysfunction and insulin resistance in patients with obstructive sleep apnea. J Diabetes Metab Disord (2013) 0.75
Atrazine induced epigenetic transgenerational inheritance of disease, lean phenotype and sperm epimutation pathology biomarkers. PLoS One (2017) 0.75
HFD-induced energy states-dependent bidirectional control of anxiety levels in mice. Int J Obes (Lond) (2017) 0.75
Fish oil supplementation and insulin sensitivity: a systematic review and meta-analysis. Lipids Health Dis (2017) 0.75
Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev (2004) 3.69
The prevalence and impact of overweight and obesity in an Australian obstetric population. Med J Aust (2006) 3.43
Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol (2010) 1.87
Aging per se does not influence glucose homeostasis: in vivo and in vitro evidence. Diabetes Care (2003) 1.62
Fat as an endocrine organ: relationship to the metabolic syndrome. Am J Med Sci (2005) 1.48
Metformin and serious adverse effects. Med J Aust (2004) 1.48
2: Recent advances in therapy of diabetes. Med J Aust (2003) 1.38
In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. J Hepatol (2003) 1.29
Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology (Carlton) (2007) 1.28
Determinants of exercise capacity in patients with type 2 diabetes. Diabetes Care (2005) 1.28
Screening for heart disease in diabetic subjects. Am Heart J (2005) 1.22
Adiponectin multimerization is dependent on conserved lysines in the collagenous domain: evidence for regulation of multimerization by alterations in posttranslational modifications. Mol Endocrinol (2006) 1.20
Update on incretin hormones. Ann N Y Acad Sci (2011) 1.15
Characterization of the transcriptional and functional effects of fibroblast growth factor-1 on human preadipocyte differentiation. FASEB J (2006) 1.07
Exercise prescription for patients with type 2 diabetes and pre-diabetes: a position statement from Exercise and Sport Science Australia. J Sci Med Sport (2011) 1.02
Resveratrol--pills to replace a healthy diet? Br J Clin Pharmacol (2011) 1.02
The risk of Barrett's esophagus associated with abdominal obesity in males and females. Int J Cancer (2012) 0.99
Association of arterial wave properties and diastolic dysfunction in patients with type 2 diabetes mellitus. Am J Cardiol (2007) 0.99
Abnormal NF-kappa B function characterizes human type 1 diabetes dendritic cells and monocytes. J Immunol (2008) 0.95
Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease. Gut (2012) 0.94
Should an oral glucose tolerance test be performed routinely in all renal transplant recipients? Clin J Am Soc Nephrol (2005) 0.94
Identification of BMP and activin membrane-bound inhibitor (BAMBI) as a potent negative regulator of adipogenesis and modulator of autocrine/paracrine adipogenic factors. Diabetes (2012) 0.94
An inhibitor of phospholipase A2 group IIA modulates adipocyte signaling and protects against diet-induced metabolic syndrome in rats. Diabetes (2012) 0.90
Effect of weight loss due to lifestyle intervention on subclinical cardiovascular dysfunction in obesity (body mass index >30 kg/m2). Am J Cardiol (2006) 0.89
A putative role for endogenous FGF-2 in FGF-1 mediated differentiation of human preadipocytes. Mol Cell Endocrinol (2011) 0.89
Determinants of changes in blood glucose response to short-term exercise training in patients with Type 2 diabetes. Clin Sci (Lond) (2008) 0.87
TNF and TNF receptor expression and insulin sensitivity in human omental and subcutaneous adipose tissue--influence of BMI and adipose distribution. Diab Vasc Dis Res (2006) 0.87
The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with chronic kidney disease: a randomised controlled trial. BMC Nephrol (2009) 0.87
Left ventricular mass in patients with type 2 diabetes is independently associated with central but not peripheral pulse pressure. Diabetes Care (2005) 0.86
High molecular weight adiponectin correlates with insulin sensitivity in patients with hepatitis C genotype 3, but not genotype 1 infection. Am J Gastroenterol (2005) 0.84
Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: a potential mechanism for olanzapine-induced insulin resistance in patients with schizophrenia. J Clin Psychopharmacol (2006) 0.84
Patients with type 2 diabetes have exaggerated brachial and central exercise blood pressure: relation to left ventricular relative wall thickness. Am J Hypertens (2008) 0.84
Acute response of blood glucose to short-term exercise training in patients with type 2 diabetes. J Sci Med Sport (2010) 0.83
Raised alanine transaminase and decreased adiponectin are features of the metabolic syndrome in patients with type 2 diabetes. Diabetes Obes Metab (2007) 0.83
Screening for coronary artery disease in patients with diabetes: a Bayesian strategy of clinical risk evaluation and exercise echocardiography. Am Heart J (2005) 0.82
Thiazolidinediones and type 2 diabetes: new drugs for an old disease. Med J Aust (2002) 0.80
Altered clot kinetics in patients with non-alcoholic fatty liver disease. Ann Hepatol (2009) 0.80
The effect of 25-hydroxyvitamin D on insulin sensitivity in obesity: is it mediated via adiponectin? Can J Physiol Pharmacol (2013) 0.80
Reduced phosphorylation of AS160 contributes to glucocorticoid-mediated inhibition of glucose uptake in human and murine adipocytes. Mol Cell Endocrinol (2008) 0.78
Application of an exercise intervention on the evolution of diastolic dysfunction in patients with diabetes mellitus: efficacy and effectiveness. Circ Heart Fail (2011) 0.78
Peroxisomal fatty acid metabolism, peroxisomal proliferator-activated receptors and non-alcoholic fatty liver disease. J Gastroenterol Hepatol (2004) 0.78
Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: a randomized controlled trial. Nephrology (Carlton) (2013) 0.77
Strengthening the case for global risk assessment of patients with high blood pressure. Am J Hypertens (2009) 0.77
Should patients with type 2 diabetes and raised liver enzymes be referred for further evaluation of liver disease? Diabetes Res Clin Pract (2008) 0.77
Inhibition of inosine monophosphate dehydrogenase reduces adipogenesis and diet-induced obesity. Biochem Biophys Res Commun (2009) 0.77
Changes in antibiotic distribution due to pancreatitis. Antimicrob Agents Chemother (2011) 0.75
Rosiglitazone and cardiovascular disease revisited. Med J Aust (2010) 0.75
Adipose tissue from pregnant women with and without gestational diabetes mellitus: insulin-sensitive but resistant to hyperosomolarity. Am J Obstet Gynecol (2005) 0.75